首页/数据集/Lipid-lowering therapy in subjects with FH or FDB of different age groups at the follow-up.

Lipid-lowering therapy in subjects with FH or FDB of different age groups at the follow-up.

Figshare2015-12-02 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/_Lipid_lowering_therapy_in_subjects_with_FH_or_FDB_of_different_age_groups_at_the_follow_up_/467100 数据链接链接失效反馈

官方服务：

资源简介：

Lipid-lowering therapy in subjects with FH or FDB of different age groups at the follow-up.

应用场景：

创建时间：

2015-12-02

家族性高胆固醇血症

基因型-表型关联

Data are presented in mean ± SD. p-values were obtained by comparing the phenotypes among the genotypes using Analysis of Variance (ANOVA).

NIAID Data Ecosystem40

FH及未服他汀人群脂多糖（LPS）数据

家族性高胆固醇血症

炎症研究

该数据集来源于中国医学科学院阜外医院心血管代谢中心血脂团队实验室，包括基因确诊的家族性高胆固醇血症（FH）患者与从未服用他汀的非FH人群的血浆LPS水平，LPS的水平差异可部分反应FH与非FH人群的LPS-NF-κB炎症通路激活状态的差异。该数据集为科研、发表论文而使用。

国家人口健康科学数据中心40

Supplementary Material for: Development of an Implementation Framework for Overcoming Underdiagnoses of Familial Hypercholesterolemia in the USA

家族性高胆固醇血症

实施科学

Familial hypercholesterolemia (FH) is a genetic condition which causes elevated low-density lipoprotein cholesterol from birth. With a prevalence of 1 in 250 and the availability of effective treatmen

DataCite Commons2021-04-14 更新30

Clinical, Anthropometric and Biochemical Characteristics of Patients with or without Genetically Confirmed Familial Hypercholesterolemia

家族性高胆固醇血症

表型-基因关联

Abstract Background: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder, characterized by a high level of low-density lipoprotein cholesterol (LDL-C) and a high risk of premat

NIAID Data Ecosystem40

Data_Sheet_1_Developing a Hybrid Risk Assessment Tool for Familial Hypercholesterolemia: A Machine Learning Study of Chinese Arteriosclerotic Cardiovascular Disease Patients.docx

家族性高胆固醇血症

机器学习在心血管疾病中的应用

BackgroundFamilial hypercholesterolemia (FH) is an autosomal-dominant genetic disorder with a high risk of premature arteriosclerotic cardiovascular disease (ASCVD). There are many alternative risk as

NIAID Data Ecosystem30

Lipid-lowering therapy in subjects with FH or FDB of different age groups at the follow-up.

资源简介：

相关数据集